 | • レポートコード：D0GIR-00694 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、転移性黒色腫治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。転移性黒色腫治療の種類別市場規模（標的化学療法、標的免疫療法、標的MAPキナーゼ療法、抗血管新生療法、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott、Pfizer、Agilent Technologies、Roche、Sanofi、GSK、Merck、Novartis、Bristol-Myer Squibb ・地域別グローバル市場分析 2015年-2020年 ・転移性黒色腫治療の北米市場（アメリカ、カナダ、メキシコ） ・転移性黒色腫治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・転移性黒色腫治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・転移性黒色腫治療の南米市場（ブラジル、アルゼンチン） ・転移性黒色腫治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：標的化学療法、標的免疫療法、標的MAPキナーゼ療法、抗血管新生療法、その他 ・用途別分析：病院、クリニック、外来手術センター、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Metastatic Melanoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Metastatic Melanoma Treatment sales will be xx in 2020 from Metastatic Melanoma Treatment million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Metastatic Melanoma Treatment market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Metastatic Melanoma Treatment industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Metastatic Melanoma Treatment and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Metastatic Melanoma Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Metastatic Melanoma Treatment market has been segmented into:
Targeted Chemotherapy
Targeted Immunotherapy
Targeted MAP-Kinase Therapy
Anti-Angiogenesis Therapy
Others
By Application, Metastatic Melanoma Treatment has been segmented into:
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Metastatic Melanoma Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Metastatic Melanoma Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Metastatic Melanoma Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Metastatic Melanoma Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Metastatic Melanoma Treatment Market Share Analysis
Metastatic Melanoma Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Metastatic Melanoma Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Metastatic Melanoma Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Metastatic Melanoma Treatment are:
Abbott
Pfizer
Agilent Technologies
Roche
Sanofi
GSK
Merck
Novartis
Bristol-Myer Squibb
Among other players domestic and global, Metastatic Melanoma Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Metastatic Melanoma Treatment Market Overview
1.1 Product Overview and Scope of Metastatic Melanoma Treatment
1.2 Classification of Metastatic Melanoma Treatment by Therapy
1.2.1 Global Metastatic Melanoma Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Metastatic Melanoma Treatment Revenue Market Share by Therapy in 2019
1.2.3 Targeted Chemotherapy
1.2.4 Targeted Immunotherapy
1.2.5 Targeted MAP-Kinase Therapy
1.2.6 Anti-Angiogenesis Therapy
1.2.7 Others
1.3 Global Metastatic Melanoma Treatment Market by End Users
1.3.1 Overview: Global Metastatic Melanoma Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global Metastatic Melanoma Treatment Market by Regions
1.4.1 Global Metastatic Melanoma Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Metastatic Melanoma Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Metastatic Melanoma Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Metastatic Melanoma Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Metastatic Melanoma Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Metastatic Melanoma Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Metastatic Melanoma Treatment Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Metastatic Melanoma Treatment Industry Impact
1.5.1 COVID-19 Potential Implications for the Metastatic Melanoma Treatment
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Metastatic Melanoma Treatment
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Metastatic Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer SWOT Analysis
2.2.4 Pfizer Product and Services
2.2.5 Pfizer Metastatic Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Agilent Technologies
2.3.1 Agilent Technologies Details
2.3.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Agilent Technologies SWOT Analysis
2.3.4 Agilent Technologies Product and Services
2.3.5 Agilent Technologies Metastatic Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Metastatic Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Metastatic Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GSK SWOT Analysis
2.6.4 GSK Product and Services
2.6.5 GSK Metastatic Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck SWOT Analysis
2.7.4 Merck Product and Services
2.7.5 Merck Metastatic Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis SWOT Analysis
2.8.4 Novartis Product and Services
2.8.5 Novartis Metastatic Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bristol-Myer Squibb
2.9.1 Bristol-Myer Squibb Details
2.9.2 Bristol-Myer Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bristol-Myer Squibb SWOT Analysis
2.9.4 Bristol-Myer Squibb Product and Services
2.9.5 Bristol-Myer Squibb Metastatic Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Metastatic Melanoma Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Metastatic Melanoma Treatment Players Market Share
3.2.2 Top 10 Metastatic Melanoma Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Metastatic Melanoma Treatment Revenue and Market Share by Regions
4.2 North America Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
5 North America Metastatic Melanoma Treatment Revenue by Countries
5.1 North America Metastatic Melanoma Treatment Revenue by Countries (2015-2020)
5.2 USA Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
6 Europe Metastatic Melanoma Treatment Revenue by Countries
6.1 Europe Metastatic Melanoma Treatment Revenue by Countries (2015-2020)
6.2 Germany Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
6.4 France Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Metastatic Melanoma Treatment Revenue by Countries
7.1 Asia-Pacific Metastatic Melanoma Treatment Revenue by Countries (2015-2020)
7.2 China Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
7.5 India Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
8 South America Metastatic Melanoma Treatment Revenue by Countries
8.1 South America Metastatic Melanoma Treatment Revenue by Countries (2015-2020)
8.2 Brazil Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Metastatic Melanoma Treatment by Countries
9.1 Middle East & Africa Metastatic Melanoma Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Metastatic Melanoma Treatment Revenue and Market Share by Therapy (2015-2020)
10.2 Global Metastatic Melanoma Treatment Market Forecast by Therapy (2019-2024)
10.3 Targeted Chemotherapy Revenue Growth Rate (2015-2025)
10.4 Targeted Immunotherapy Revenue Growth Rate (2015-2025)
10.5 Targeted MAP-Kinase Therapy Revenue Growth Rate (2015-2025)
10.6 Anti-Angiogenesis Therapy Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Metastatic Melanoma Treatment Market Segment by End Users
11.1 Global Metastatic Melanoma Treatment Revenue Market Share by End Users (2015-2020)
11.2 Metastatic Melanoma Treatment Market Forecast by End Users (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Metastatic Melanoma Treatment Market Size Forecast (2021-2025)
12.1 Global Metastatic Melanoma Treatment Market Size Forecast (2021-2025)
12.2 Global Metastatic Melanoma Treatment Market Forecast by Regions (2021-2025)
12.3 North America Metastatic Melanoma Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Metastatic Melanoma Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Metastatic Melanoma Treatment Revenue Market Forecast (2021-2025)
12.6 South America Metastatic Melanoma Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Metastatic Melanoma Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Metastatic Melanoma Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Metastatic Melanoma Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Metastatic Melanoma Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Metastatic Melanoma Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Metastatic Melanoma Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Abbott Corporate Information, Location and Competitors
Table 7. Abbott Metastatic Melanoma Treatment Major Business
Table 8. Abbott Metastatic Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 9. Abbott SWOT Analysis
Table 10. Abbott Metastatic Melanoma Treatment Product and Solutions
Table 11. Abbott Metastatic Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Pfizer Corporate Information, Location and Competitors
Table 13. Pfizer Metastatic Melanoma Treatment Major Business
Table 14. Pfizer Metastatic Melanoma Treatment Total Revenue (USD Million) (2018-2019)
Table 15. Pfizer SWOT Analysis
Table 16. Pfizer Metastatic Melanoma Treatment Product and Solutions
Table 17. Pfizer Metastatic Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Agilent Technologies Corporate Information, Location and Competitors
Table 19. Agilent Technologies Metastatic Melanoma Treatment Major Business
Table 20. Agilent Technologies Metastatic Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 21. Agilent Technologies SWOT Analysis
Table 22. Agilent Technologies Metastatic Melanoma Treatment Product and Solutions
Table 23. Agilent Technologies Metastatic Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Roche Corporate Information, Location and Competitors
Table 25. Roche Metastatic Melanoma Treatment Major Business
Table 26. Roche Metastatic Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 27. Roche SWOT Analysis
Table 28. Roche Metastatic Melanoma Treatment Product and Solutions
Table 29. Roche Metastatic Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Sanofi Corporate Information, Location and Competitors
Table 31. Sanofi Metastatic Melanoma Treatment Major Business
Table 32. Sanofi Metastatic Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 33. Sanofi SWOT Analysis
Table 34. Sanofi Metastatic Melanoma Treatment Product and Solutions
Table 35. Sanofi Metastatic Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. GSK Corporate Information, Location and Competitors
Table 37. GSK Metastatic Melanoma Treatment Major Business
Table 38. GSK Metastatic Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 39. GSK SWOT Analysis
Table 40. GSK Metastatic Melanoma Treatment Product and Solutions
Table 41. GSK Metastatic Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Merck Corporate Information, Location and Competitors
Table 43. Merck Metastatic Melanoma Treatment Major Business
Table 44. Merck Metastatic Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 45. Merck SWOT Analysis
Table 46. Merck Metastatic Melanoma Treatment Product and Solutions
Table 47. Merck Metastatic Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Novartis Corporate Information, Location and Competitors
Table 49. Novartis Metastatic Melanoma Treatment Major Business
Table 50. Novartis Metastatic Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 51. Novartis SWOT Analysis
Table 52. Novartis Metastatic Melanoma Treatment Product and Solutions
Table 53. Novartis Metastatic Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Bristol-Myer Squibb Corporate Information, Location and Competitors
Table 55. Bristol-Myer Squibb Metastatic Melanoma Treatment Major Business
Table 56. Bristol-Myer Squibb Metastatic Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 57. Bristol-Myer Squibb SWOT Analysis
Table 58. Bristol-Myer Squibb Metastatic Melanoma Treatment Product and Solutions
Table 59. Bristol-Myer Squibb Metastatic Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Global Metastatic Melanoma Treatment Revenue (Million USD) by Players (2015-2020)
Table 61. Global Metastatic Melanoma Treatment Revenue Share by Players (2015-2020)
Table 62. Global Metastatic Melanoma Treatment Revenue (Million USD) by Regions (2015-2020)
Table 63. Global Metastatic Melanoma Treatment Revenue Market Share by Regions (2015-2020)
Table 64. North America Metastatic Melanoma Treatment Revenue by Countries (2015-2020)
Table 65. North America Metastatic Melanoma Treatment Revenue Market Share by Countries (2015-2020)
Table 66. Europe Metastatic Melanoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 67. Asia-Pacific Metastatic Melanoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 68. South America Metastatic Melanoma Treatment Revenue by Countries (2015-2020)
Table 69. South America Metastatic Melanoma Treatment Revenue Market Share by Countries (2015-2020)
Table 70. Middle East and Africa Metastatic Melanoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 71. Middle East and Africa Metastatic Melanoma Treatment Revenue Market Share by Countries (2015-2020)
Table 72. Global Metastatic Melanoma Treatment Revenue (Million USD) by Type (2015-2020)
Table 73. Global Metastatic Melanoma Treatment Revenue Share by Type (2015-2020)
Table 74. Global Metastatic Melanoma Treatment Revenue Forecast by Type (2021-2025)
Table 75. Global Metastatic Melanoma Treatment Revenue by Application (2015-2020)
Table 76. Global Metastatic Melanoma Treatment Revenue Share by Application (2015-2020)
Table 77. Global Metastatic Melanoma Treatment Revenue Forecast by Application (2021-2025)
Table 78. Global Metastatic Melanoma Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Metastatic Melanoma Treatment Picture
Figure 2. Global Metastatic Melanoma Treatment Revenue Market Share by Therapy in 2019
Figure 3. Targeted Chemotherapy Picture
Figure 4. Targeted Immunotherapy Picture
Figure 5. Targeted MAP-Kinase Therapy Picture
Figure 6. Anti-Angiogenesis Therapy Picture
Figure 7. Others Picture
Figure 8. Metastatic Melanoma Treatment Revenue Market Share by End Users in 2019
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Ambulatory Surgical Centers Picture
Figure 12. Others Picture
Figure 13. Global Metastatic Melanoma Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Metastatic Melanoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Metastatic Melanoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Metastatic Melanoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Metastatic Melanoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Metastatic Melanoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Metastatic Melanoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Metastatic Melanoma Treatment Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Metastatic Melanoma Treatment Revenue Market Share in 2019
Figure 22. Global Top 10 Players Metastatic Melanoma Treatment Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Metastatic Melanoma Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Metastatic Melanoma Treatment Revenue Market Share by Regions (2015-2020)
Figure 26. Global Metastatic Melanoma Treatment Revenue Market Share by Regions in 2018
Figure 27. North America Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Europe Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 30. South America Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 32. North America Metastatic Melanoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 33. North America Metastatic Melanoma Treatment Revenue Market Share by Countries in 2019
Figure 34. USA Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Canada Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 37. Europe Metastatic Melanoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Metastatic Melanoma Treatment Revenue Market Share by Countries in 2019
Figure 39. Germany Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 40. UK Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 41. France Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Russia Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Italy Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Metastatic Melanoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Metastatic Melanoma Treatment Revenue Market Share by Countries in 2019
Figure 46. China Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Japan Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Korea Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 49. India Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 51. South America Metastatic Melanoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. South America Metastatic Melanoma Treatment Revenue Market Share by Countries in 2019
Figure 53. Brazil Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Metastatic Melanoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Metastatic Melanoma Treatment Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 58. UAE Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Metastatic Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 61. Global Metastatic Melanoma Treatment Revenue Share by Type (2015-2020)
Figure 62. Global Metastatic Melanoma Treatment Revenue Share by Type in 2019
Figure 63. Global Metastatic Melanoma Treatment Market Share Forecast by Type (2021-2025)
Figure 64. Global Targeted Chemotherapy Revenue Growth Rate (2015-2020)
Figure 65. Global Targeted Immunotherapy Revenue Growth Rate (2015-2020)
Figure 66. Global Targeted MAP-Kinase Therapy Revenue Growth Rate (2015-2020)
Figure 67. Global Anti-Angiogenesis Therapy Revenue Growth Rate (2015-2020)
Figure 68. Global Others Revenue Growth Rate (2015-2020)
Figure 69. Global Metastatic Melanoma Treatment Revenue Share by Application (2015-2020)
Figure 70. Global Metastatic Melanoma Treatment Revenue Share by Application in 2019
Figure 71. Global Metastatic Melanoma Treatment Market Share Forecast by Application (2021-2025)
Figure 72. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 73. Global Clinics Revenue Growth Rate (2015-2020)
Figure 74. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 75. Global Others Revenue Growth Rate (2015-2020)
Figure 76. Global Metastatic Melanoma Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Metastatic Melanoma Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Metastatic Melanoma Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Metastatic Melanoma Treatment Revenue Market Forecast (2021-2025)
Figure 80. Europe Metastatic Melanoma Treatment Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Metastatic Melanoma Treatment Revenue Market Forecast (2021-2025)
Figure 82. South America Metastatic Melanoma Treatment Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Metastatic Melanoma Treatment Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
悪性黒色腫治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Malignant Melanoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…- 非黒色腫皮膚がん治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Non-Melanoma Skin Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Non-Melano…
- 転移性大腸がん手術の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Metastatic Colorectal Cancer Surgery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metastat…
- 非黒色腫皮膚がんの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Non-Melanoma Skin Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Non-Melanoma Skin Ca…
- 黒色腫がんの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Melanoma Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Melanoma Cancer market report…